Gundert-Remy U - Search Results

1

The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.

Gundert-Remy U, Sonich-Mullin C; IPCS Uncertainty and Variability Planning Workgroup and Drafting Group (International Program on Chemical Safety's). Gundert-Remy U, et al. Sci Total Environ. 2002 Apr 8;288(1-2):3-11. doi: 10.1016/s0048-9697(01)01108-1. Sci Total Environ. 2002. PMID: 12013545

2

The use of in vitro data in risk assessment.

Bernauer U, Oberemm A, Madle S, Gundert-Remy U. Bernauer U, et al. Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):176-81. doi: 10.1111/j.1742-7843.2005.pto960306.x. Basic Clin Pharmacol Toxicol. 2005. PMID: 15733212 Review.

3

The use of toxicodynamics in risk assessment.

Heinrich-Hirsch B, Madle S, Oberemm A, Gundert-Remy U. Heinrich-Hirsch B, et al. Toxicol Lett. 2001 Mar 31;120(1-3):131-41. doi: 10.1016/s0378-4274(01)00291-0. Toxicol Lett. 2001. PMID: 11323170

4

Modelling of residual variability in toxicokinetic studies with sparse sampling: the case of tetrahydronaphthalene.

Meineke I, Eisele J, Certa H, Gundert-Remy UM. Meineke I, et al. Arch Toxicol. 1998 Dec;72(12):807-10. doi: 10.1007/s002040050577. Arch Toxicol. 1998. PMID: 9950078

5

How can toxicogenomics inform risk assessment?

Oberemm A, Onyon L, Gundert-Remy U. Oberemm A, et al. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):592-8. doi: 10.1016/j.taap.2005.01.044. Toxicol Appl Pharmacol. 2005. PMID: 15990130 Review.

6

Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scaling.

Mielke H, Gundert A, Abraham K, Gundert-Remy U. Mielke H, et al. Toxicology. 2005 Oct 30;214(3):256-67. doi: 10.1016/j.tox.2005.06.018. Epub 2005 Aug 1. Toxicology. 2005. PMID: 16055256

7

Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarin.

Mielke H, Abraham K, Götz M, Vieth B, Lampen A, Luch A, Gundert-Remy U. Mielke H, et al. Toxicol Lett. 2011 Apr 25;202(2):100-10. doi: 10.1016/j.toxlet.2011.01.022. Epub 2011 Feb 1. Toxicol Lett. 2011. PMID: 21291965

8

CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals.

Bernauer U, Vieth B, Ellrich R, Heinrich-Hirsch B, Jänig GR, Gundert-Remy U. Bernauer U, et al. Arch Toxicol. 2000 Feb;73(12):618-24. doi: 10.1007/s002040050016. Arch Toxicol. 2000. PMID: 10741472

9

Chronic oral LOAEL prediction by using a commercially available computational QSAR tool.

Rupp B, Appel KE, Gundert-Remy U. Rupp B, et al. Arch Toxicol. 2010 Sep;84(9):681-8. doi: 10.1007/s00204-010-0532-x. Epub 2010 Mar 12. Arch Toxicol. 2010. PMID: 20224925

10

Immunochemical analysis of cytochrome P450 variability in human leukapheresed samples and its consequences for the risk assessment process.

Bernauer U, Garritsen H, Heinrich-Hirsch B, Gundert-Remy U. Bernauer U, et al. Regul Toxicol Pharmacol. 2003 Apr;37(2):318-27. doi: 10.1016/s0273-2300(03)00012-6. Regul Toxicol Pharmacol. 2003. PMID: 12726760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters